Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
A calorimetric assay for dicyclomine hydrochloride using bromocresol green.

Journal of pharmaceutical and biomedical analysis

Raggi MA, Cavrini V, Di Pietra AM.
PMID: 16867689
J Pharm Biomed Anal. 1985;3(3):287-91. doi: 10.1016/0731-7085(85)80034-0.

No abstract available.

Cite
Raggi MA, Cavrini V, Di Pietra AM. A calorimetric assay for dicyclomine hydrochloride using bromocresol green. J Pharm Biomed Anal. 1985;3(3):287-91doi: 10.1016/0731-7085(85)80034-0.
Raggi, M. A., Cavrini, V., & Di Pietra, A. M. (1985). A calorimetric assay for dicyclomine hydrochloride using bromocresol green. Journal of pharmaceutical and biomedical analysis, 3(3), 287-91. https://doi.org/10.1016/0731-7085(85)80034-0
Raggi, M A, et al. "A calorimetric assay for dicyclomine hydrochloride using bromocresol green." Journal of pharmaceutical and biomedical analysis vol. 3,3 (1985): 287-91. doi: https://doi.org/10.1016/0731-7085(85)80034-0
Raggi MA, Cavrini V, Di Pietra AM. A calorimetric assay for dicyclomine hydrochloride using bromocresol green. J Pharm Biomed Anal. 1985;3(3):287-91. doi: 10.1016/0731-7085(85)80034-0. PMID: 16867689.
Copy Download .nbib Format: NLM
Pharmacological Basis for the Medicinal Use of Lepidium sativum in Airways Disorders.

Evidence-based complementary and alternative medicine : eCAM

Rehman NU, Khan AU, Alkharfy KM, Gilani AH.
PMID: 22291849
Evid Based Complement Alternat Med. 2012;2012:596524. doi: 10.1155/2012/596524. Epub 2012 Jan 15.

Lepidium sativum is widely used in folk medicine for treatment of hyperactive airways disorders, such as asthma, bronchitis and cough. The crude extract of Lepidium sativum (Ls.Cr) inhibited carbachol (CCh, 1 μM-) and K(+) (80 mM-) induced contractions in...

Cite
Rehman NU, Khan AU, Alkharfy KM, et al. Pharmacological Basis for the Medicinal Use of Lepidium sativum in Airways Disorders. Evid Based Complement Alternat Med. 2012;2012:596524doi: 10.1155/2012/596524.
Rehman, N. U., Khan, A. U., Alkharfy, K. M., & Gilani, A. H. (2012). Pharmacological Basis for the Medicinal Use of Lepidium sativum in Airways Disorders. Evidence-based complementary and alternative medicine : eCAM, 2012596524. https://doi.org/10.1155/2012/596524
Rehman, Najeeb-Ur, et al. "Pharmacological Basis for the Medicinal Use of Lepidium sativum in Airways Disorders." Evidence-based complementary and alternative medicine : eCAM vol. 2012 (2012): 596524. doi: https://doi.org/10.1155/2012/596524
Rehman NU, Khan AU, Alkharfy KM, Gilani AH. Pharmacological Basis for the Medicinal Use of Lepidium sativum in Airways Disorders. Evid Based Complement Alternat Med. 2012;2012:596524. doi: 10.1155/2012/596524. Epub 2012 Jan 15. PMID: 22291849; PMCID: PMC3265128.
Copy Download .nbib Format: NLM
Multiple Mechanisms of Flaxseed: Effectiveness in Inflammatory Bowel Disease.

Evidence-based complementary and alternative medicine : eCAM

Palla AH, Gilani AU, Bashir S, Ur Rehman N.
PMID: 32765633
Evid Based Complement Alternat Med. 2020 Jul 12;2020:7974835. doi: 10.1155/2020/7974835. eCollection 2020.

MATERIALS AND METHODS: Aqueous-methanolic crude extracts of Flaxseed (Fs.Cr) and Flaxseed oil were tested against 6% acetic acid- (AA-) induced colitis in BALB/c mice. Microscopic damage parameters of the hematoxylin and eosin-stained and periodic acid-Schiff-alcian blue-stained sections of the...

Cite
Palla AH, Gilani AU, Bashir S, et al. Multiple Mechanisms of Flaxseed: Effectiveness in Inflammatory Bowel Disease. Evid Based Complement Alternat Med. 2020;2020:7974835doi: 10.1155/2020/7974835.
Palla, A. H., Gilani, A. U., Bashir, S., & Ur Rehman, N. (2020). Multiple Mechanisms of Flaxseed: Effectiveness in Inflammatory Bowel Disease. Evidence-based complementary and alternative medicine : eCAM, 20207974835. https://doi.org/10.1155/2020/7974835
Palla, Amber Hanif, et al. "Multiple Mechanisms of Flaxseed: Effectiveness in Inflammatory Bowel Disease." Evidence-based complementary and alternative medicine : eCAM vol. 2020 (2020): 7974835. doi: https://doi.org/10.1155/2020/7974835
Palla AH, Gilani AU, Bashir S, Ur Rehman N. Multiple Mechanisms of Flaxseed: Effectiveness in Inflammatory Bowel Disease. Evid Based Complement Alternat Med. 2020 Jul 12;2020:7974835. doi: 10.1155/2020/7974835. eCollection 2020. PMID: 32765633; PMCID: PMC7374215.
Copy Download .nbib Format: NLM
Pain-relieving agents for infantile colic.

The Cochrane database of systematic reviews

Biagioli E, Tarasco V, Lingua C, Moja L, Savino F.
PMID: 27631535
Cochrane Database Syst Rev. 2016 Sep 16;9:CD009999. doi: 10.1002/14651858.CD009999.pub2.

BACKGROUND: Infantile colic is a common disorder in the first months of life, affecting somewhere between 4% and 28% of infants worldwide, depending on geography and definitions used. Although it is self limiting and resolves by four months of...

Cite
Biagioli E, Tarasco V, Lingua C, et al. Pain-relieving agents for infantile colic. Cochrane Database Syst Rev. 2016;9:CD009999doi: 10.1002/14651858.CD009999.pub2.
Biagioli, E., Tarasco, V., Lingua, C., Moja, L., & Savino, F. (2016). Pain-relieving agents for infantile colic. The Cochrane database of systematic reviews, 9CD009999. https://doi.org/10.1002/14651858.CD009999.pub2
Biagioli, Elena, et al. "Pain-relieving agents for infantile colic." The Cochrane database of systematic reviews vol. 9 (2016): CD009999. doi: https://doi.org/10.1002/14651858.CD009999.pub2
Biagioli E, Tarasco V, Lingua C, Moja L, Savino F. Pain-relieving agents for infantile colic. Cochrane Database Syst Rev. 2016 Sep 16;9:CD009999. doi: 10.1002/14651858.CD009999.pub2. PMID: 27631535; PMCID: PMC6457752.
Copy Download .nbib Format: NLM
A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis.

Journal of pharmacy practice

Eid TJ, Horton M, Hendrix C, Yu JM, Browning EA, Malhotra A.
PMID: 34670427
J Pharm Pract. 2021 Oct 20;8971900211052829. doi: 10.1177/08971900211052829. Epub 2021 Oct 20.

BACKGROUND: Contraction alkalosis is characterized by low serum sodium and chloride and high serum carbon dioxide and bicarbonate levels.CASE REPORT: A 28-year-old Caucasian active-duty male with a history of autosomal dominant polycystic kidney disease and diarrhea-predominant Irritable Bowel Syndrome...

Cite
Eid TJ, Horton M, Hendrix C, et al. A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis. J Pharm Pract. 2021;8971900211052829doi: 10.1177/08971900211052829.
Eid, T. J., Horton, M., Hendrix, C., Yu, J. M., Browning, E. A., & Malhotra, A. (2021). A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis. Journal of pharmacy practice, 8971900211052829. https://doi.org/10.1177/08971900211052829
Eid, Tony J, et al. "A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis." Journal of pharmacy practice vol. (2021): 8971900211052829. doi: https://doi.org/10.1177/08971900211052829
Eid TJ, Horton M, Hendrix C, Yu JM, Browning EA, Malhotra A. A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis. J Pharm Pract. 2021 Oct 20;8971900211052829. doi: 10.1177/08971900211052829. Epub 2021 Oct 20. PMID: 34670427.
Copy Download .nbib Format: NLM
Investigation of anti-Parkinson activity of dicyclomine.

The International journal of neuroscience

Sanawar M, Saleem U, Anwar F, Nazir S, Akhtar MF, Ahmad B, Ismail T.
PMID: 32847457
Int J Neurosci. 2020 Sep 11;1-14. doi: 10.1080/00207454.2020.1815732. Epub 2020 Sep 11.

BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder. The major causative factors that progress the PD are age, genetic abnormalities, environmental factors and degeneration of dopamine neurons in substantia nigra. PD normally exerts a tonic inhibitory effect on...

Cite
Sanawar M, Saleem U, Anwar F, et al. Investigation of anti-Parkinson activity of dicyclomine. Int J Neurosci. 2020;1-14doi: 10.1080/00207454.2020.1815732.
Sanawar, M., Saleem, U., Anwar, F., Nazir, S., Akhtar, M. F., Ahmad, B., & Ismail, T. (2020). Investigation of anti-Parkinson activity of dicyclomine. The International journal of neuroscience, 1-14. https://doi.org/10.1080/00207454.2020.1815732
Sanawar, Maham, et al. "Investigation of anti-Parkinson activity of dicyclomine." The International journal of neuroscience vol. (2020): 1-14. doi: https://doi.org/10.1080/00207454.2020.1815732
Sanawar M, Saleem U, Anwar F, Nazir S, Akhtar MF, Ahmad B, Ismail T. Investigation of anti-Parkinson activity of dicyclomine. Int J Neurosci. 2020 Sep 11;1-14. doi: 10.1080/00207454.2020.1815732. Epub 2020 Sep 11. PMID: 32847457.
Copy Download .nbib Format: NLM
Table: Safety of drugs for IBS in pregnancy and lactation (online only).

The Medical letter on drugs and therapeutics

[No authors listed]
PMID: 32324174
Med Lett Drugs Ther. 2020 Mar 23;62(1594):e48-e49.

No abstract available.

Cite
Table: Safety of drugs for IBS in pregnancy and lactation (online only). Med Lett Drugs Ther. 2020;62(1594):e48-e49
(2020). Table: Safety of drugs for IBS in pregnancy and lactation (online only). The Medical letter on drugs and therapeutics, 62(1594), e48-e49.
"Table: Safety of drugs for IBS in pregnancy and lactation (online only)." The Medical letter on drugs and therapeutics vol. 62,1594 (2020): e48-e49.
Table: Safety of drugs for IBS in pregnancy and lactation (online only). Med Lett Drugs Ther. 2020 Mar 23;62(1594):e48-e49. PMID: 32324174.
Copy Download .nbib Format: NLM
Ameliorative effect of galantamine on acetic acid-induced colitis in rats.

Research in pharmaceutical sciences

Mahdavi NS, Talebi A, Minaiyan M.
PMID: 31798655
Res Pharm Sci. 2019 Oct 04;14(5):391-399. doi: 10.4103/1735-5362.268199. eCollection 2019 Oct.

Galantamine (GAL) is a drug for treating Alzheimer's disease which has reasonable and no significant side effects. Studies have shown that GAL possesses antioxidant, anti-inflammatory, and cholinomimetic effects that might be beneficial for inflammatory bowel disease. Therefore, this study...

Cite
Mahdavi NS, Talebi A, Minaiyan M. Ameliorative effect of galantamine on acetic acid-induced colitis in rats. Res Pharm Sci. 2019;14(5):391-399doi: 10.4103/1735-5362.268199.
Mahdavi, N. S., Talebi, A., & Minaiyan, M. (2019). Ameliorative effect of galantamine on acetic acid-induced colitis in rats. Research in pharmaceutical sciences, 14(5), 391-399. https://doi.org/10.4103/1735-5362.268199
Mahdavi, Niloofar-Sadat, et al. "Ameliorative effect of galantamine on acetic acid-induced colitis in rats." Research in pharmaceutical sciences vol. 14,5 (2019): 391-399. doi: https://doi.org/10.4103/1735-5362.268199
Mahdavi NS, Talebi A, Minaiyan M. Ameliorative effect of galantamine on acetic acid-induced colitis in rats. Res Pharm Sci. 2019 Oct 04;14(5):391-399. doi: 10.4103/1735-5362.268199. eCollection 2019 Oct. PMID: 31798655; PMCID: PMC6827195.
Copy Download .nbib Format: NLM
Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer.

Cancer management and research

Schaefer ES, Baik C.
PMID: 27069372
Cancer Manag Res. 2016 Mar 24;8:33-8. doi: 10.2147/CMAR.S96471. eCollection 2016.

Anaplastic lymphoma kinase (ALK) gene fusions occur in 3%-7% of non-small-cell lung cancer (NSCLC) cases. Ceritinib, a once-daily, oral ALK inhibitor, has activity against crizotinib-resistant and crizotinib-naïve NSCLC, including brain metastases. Ceritinib (Zykadia™) was granted accelerated approval by the...

Cite
Schaefer ES, Baik C. Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer. Cancer Manag Res. 2016;8:33-8doi: 10.2147/CMAR.S96471.
Schaefer, E. S., & Baik, C. (2016). Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer. Cancer management and research, 833-8. https://doi.org/10.2147/CMAR.S96471
Schaefer, Eric S, and Baik, Christina. "Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer." Cancer management and research vol. 8 (2016): 33-8. doi: https://doi.org/10.2147/CMAR.S96471
Schaefer ES, Baik C. Proactive management strategies for potential gastrointestinal adverse reactions with ceritinib in patients with advanced ALK-positive non-small-cell lung cancer. Cancer Manag Res. 2016 Mar 24;8:33-8. doi: 10.2147/CMAR.S96471. eCollection 2016. PMID: 27069372; PMCID: PMC4818057.
Copy Download .nbib Format: NLM
Current gut-directed therapies for irritable bowel syndrome.

Current treatment options in gastroenterology

Chang HY, Kelly EC, Lembo AJ.
PMID: 16836950
Curr Treat Options Gastroenterol. 2006 Jul;9(4):314-23. doi: 10.1007/s11938-006-0013-8.

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that can present with a wide array of symptoms that make treatment difficult. Current therapies are directed at relieving symptoms of abdominal pain or discomfort, bloating, constipation, and diarrhea. Pharmacologic...

Cite
Chang HY, Kelly EC, Lembo AJ. Current gut-directed therapies for irritable bowel syndrome. Curr Treat Options Gastroenterol. 2006;9(4):314-23doi: 10.1007/s11938-006-0013-8.
Chang, H. Y., Kelly, E. C., & Lembo, A. J. (2006). Current gut-directed therapies for irritable bowel syndrome. Current treatment options in gastroenterology, 9(4), 314-23. https://doi.org/10.1007/s11938-006-0013-8
Chang, Howard Y, et al. "Current gut-directed therapies for irritable bowel syndrome." Current treatment options in gastroenterology vol. 9,4 (2006): 314-23. doi: https://doi.org/10.1007/s11938-006-0013-8
Chang HY, Kelly EC, Lembo AJ. Current gut-directed therapies for irritable bowel syndrome. Curr Treat Options Gastroenterol. 2006 Jul;9(4):314-23. doi: 10.1007/s11938-006-0013-8. PMID: 16836950.
Copy Download .nbib Format: NLM
Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: In vitro and in vivo evaluation.

Current drug delivery

Sher M, Sarfaraz RM, Iqbal S, Hussain MA, Naeem-Ul-Hassan M, Hassan F, Bukhari SNA.
PMID: 34353263
Curr Drug Deliv. 2021 Aug 05; doi: 10.2174/1567201818666210805153347. Epub 2021 Aug 05.

OBJECTIVE: The objective of present study was to design novel colon targeted delivery of dicyclomine Hydrochloride (DCH) microsponges.METHODS: Microsponges (MS1-MS4) based on different ratios of hydroxypropylmethylcellulose (HPMC) and DCH was prepared by quasi-emulsion solvent diffusion method. Micro-sponges were analyzed...

Cite
Sher M, Sarfaraz RM, Iqbal S, et al. Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: In vitro and in vivo evaluation. Curr Drug Deliv. 2021;doi: 10.2174/1567201818666210805153347.
Sher, M., Sarfaraz, R. M., Iqbal, S., Hussain, M. A., Naeem-Ul-Hassan, M., Hassan, F., & Bukhari, S. N. A. (2021). Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: In vitro and in vivo evaluation. Current drug delivery, . https://doi.org/10.2174/1567201818666210805153347
Sher, Muhammad, et al. "Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: In vitro and in vivo evaluation." Current drug delivery vol. (2021). doi: https://doi.org/10.2174/1567201818666210805153347
Sher M, Sarfaraz RM, Iqbal S, Hussain MA, Naeem-Ul-Hassan M, Hassan F, Bukhari SNA. Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: In vitro and in vivo evaluation. Curr Drug Deliv. 2021 Aug 05; doi: 10.2174/1567201818666210805153347. Epub 2021 Aug 05. PMID: 34353263.
Copy Download .nbib Format: NLM
Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic.

Pain research and treatment

Porwal A, Mahajan AD, Oswal DS, Erram SS, Sheth DN, Balamurugan S, Kamat V, Enadle RP, Badadare A, Bhatnagar SK, Walvekar RS, Dhorepatil S, Naik RC, Basu I, Kshirsagar SN, Keny JV, Sengupta S.
PMID: 22577544
Pain Res Treat. 2012;2012:295926. doi: 10.1155/2012/295926. Epub 2012 Apr 23.

Objective. To evaluate the efficacy and tolerability of a fixed-dose combination of dexketoprofen and dicyclomine (DXD) injection in patients with acute renal colic. Patients and Methods. Two hundred and seventeen patients were randomized to receive either DXD (n =...

Cite
Porwal A, Mahajan AD, Oswal DS, et al. Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic. Pain Res Treat. 2012;2012:295926doi: 10.1155/2012/295926.
Porwal, A., Mahajan, A. D., Oswal, D. S., Erram, S. S., Sheth, D. N., Balamurugan, S., Kamat, V., Enadle, R. P., Badadare, A., Bhatnagar, S. K., Walvekar, R. S., Dhorepatil, S., Naik, R. C., Basu, I., Kshirsagar, S. N., Keny, J. V., & Sengupta, S. (2012). Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic. Pain research and treatment, 2012295926. https://doi.org/10.1155/2012/295926
Porwal, A, et al. "Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic." Pain research and treatment vol. 2012 (2012): 295926. doi: https://doi.org/10.1155/2012/295926
Porwal A, Mahajan AD, Oswal DS, Erram SS, Sheth DN, Balamurugan S, Kamat V, Enadle RP, Badadare A, Bhatnagar SK, Walvekar RS, Dhorepatil S, Naik RC, Basu I, Kshirsagar SN, Keny JV, Sengupta S. Efficacy and tolerability of fixed-dose combination of dexketoprofen and dicyclomine injection in acute renal colic. Pain Res Treat. 2012;2012:295926. doi: 10.1155/2012/295926. Epub 2012 Apr 23. PMID: 22577544; PMCID: PMC3347880.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries